Chicago's mayor is proposing to change the way police serve search warrants, seeking to regain public trust after police stormed into the wrong home and forced a woman to stand naked in handcuffs for several minutes. (March 3)
Chicago's mayor is proposing to change the way police serve search warrants, seeking to regain public trust after police stormed into the wrong home and forced a woman to stand naked in handcuffs for several minutes. (March 3)
The "Investigation Report on China's Ambroxol Market, 2021-2025" report has been added to ResearchAndMarkets.com's offering.
(Bloomberg) -- Panasonic Corp. has agreed to take over U.S. artificial intelligence software developer Blue Yonder for $7.1 billion in one of the biggest acquisitions for the Japanese firm.Panasonic, which already has a 20% stake in Blue Yonder, will buy the rest of the AI firm’s shares from New Mountain Capital and funds managed by Blackstone Group Inc. for $5.6 billion, according to a statement on Friday, confirming an earlier Bloomberg News report. Including repayment of outstanding debt, Panasonic’s total investment will amount to $7.1 billion.The announcement came less than a year after Panasonic acquired the minority stake in Blue Yonder for $800 million, giving the AI firm an enterprise value of $5.5 billion. Panasonic’s latest buyout offer will value the Scottsdale, Arizona-based company at $8.5 billion.The Japanese firm will fund the transaction with cash as well as a bridge loan. The deal is expected to close by the end of this year.Shares in Panasonic on Friday plunged and touched their lowest level since Jan. 18 in Tokyo after the Bloomberg News report. The stock fell 3.5% at the close.”It’s a good direction for Panasonic, to target the U.S. market,” said Bloomberg Intelligence analyst Masahiro Wakasugi. But the valuation “is not cheap and we will have to wait to see how they fare after the merger to evaluate it.”Blue Yonder, founded in 1985 and formerly known as JDA Software Inc., makes supply-chain management software and uses artificial intelligence to predict product demand. Its revenue was more than $1 billion last year, according to the statement. It counts Best Buy Co., Coca-Cola Co. and Walmart Inc. among its over 3,000 customers globally.Panasonic’s buyout offer will see Blue Yonder scrapping its listing plans. The AI firm this month confidentially filed for a U.S. initial public offering.(Updates with analyst’s comment in the sixth paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
(Bloomberg) -- News of the blowup spread through financial circles in Tokyo to the pulse of a familiar refrain: not again.Nomura Holdings Inc. had run into trouble far from home, this time, with the giant implosion of Archegos Capital Management in New York. Few institutions have been as humbled by the Archegos debacle as Nomura, the forever-striving giant of Japanese finance.The question now is how, or perhaps whether, Nomura can shake off this latest blow and press on with its global ambitions. Analysts wonder if heads will roll over the Archegos losses or if Nomura will quit certain businesses.Whatever happens, breaking into the big leagues in New York looks as daunting as ever, for a brokerage that’s been eyeing Wall Street ever since founder Tokushichi Nomura first toured the city in 1908.“Nomura has yet to be able to join the Wall Street club,” said Hideyasu Ban, a finance analyst at Jefferies Financial Group Inc. in Tokyo. “Even those well-established financial firms in the European continent haven’t had many successes in the U.S.”Nomura likely trails only Credit Suisse Group AG among banks posting the biggest losses from the family office collapse that saw almost $20 billion vanish in two days. Nomura has only said its claim was about $2 billion. More details on the extent of the damage may emerge Tuesday when the firm reports fourth-quarter results.While Nomura wasn’t the only firm caught out by the debacle at Archegos, the setback adds to a list of stumbles for the Japanese firm as it takes on global risk to offset slower growth at home and vies to compete with its larger, more agile U.S. rivals.Next StepsNomura, joined by Japanese peers Mitsubishi UFJ Financial Group Inc. and Mizuho Financial Group Inc. in facing losses linked to Archegos, is already taking steps to deal with the fallout. The firm is tightening credit for hedge fund clients as part of a review of its prime brokerage, which may result in a scaled-back business, people familiar with the matter have said. Nomura is also drawing up a list of clients that will be encouraged to move their business elsewhere because they don’t use the full spectrum of its services, one person said. Japanese regulators are conducting their own review.A representative for Nomura declined to comment. A spokesman for MUFG said the risk controls were working, “but we take it seriously that we were not able to detect it early. We will work to improve and enhance risk management.” The bank declined to name the client behind the loss. A Mizuho spokeswoman declined to comment beyond saying no events would affect its profit forecast. Shares in the three firms were little changed in Tokyo Friday.The Nomura losses add to the pressure on Kentaro Okuda, a company lifer who took over as chief executive officer a year ago and once ran the North American business. As recently as December, Okuda was downplaying the risk of his global operations.“I still feel that our international business is seen as unstable,” he said at a conference. “Thanks to continued efforts over the past few years, we are transforming into an organization capable of delivering consistent revenues in spite of market turbulence.”Okuda led a restructuring of the wholesale division starting in 2019 to focus on businesses that Nomura is good at, following three rounds of similar overhauls and cutbacks. The conclusion: the prime brokerage should remain, allowing the firm to lend money and securities to hedge funds and other institutional investors.Since it lacks the balance sheet and deposit-taking heft of its bigger U.S. rivals, Nomura also saw an opportunity in small corners of the derivatives markets such as structured finance.Despite the push, Nomura has never been a big player in the prime broker space, making the massive Archegos hit all the more surprising. Archegos founder Bill Hwang put on so many bets with so many banks, the lenders weren’t aware of how over leveraged he was until some of the underlying stocks including ViacomCBS Inc. crashed.While firms such as Goldman Sachs Group Inc. and Wells Fargo & Co. were able to unload their shares without suffering much damage, the Japanese banks -- along with Credit Suisse and Morgan Stanley -- were slower off the mark and took bigger hits.The Archegos mess signals Nomura is repeating past mistakes of taking on too much risk in a single market, said JPMorgan Chase & Co. analyst Wataru Otsuka.“The latest case indicates that there has been some unbalanced risk-taking,” said Otsuka, adding the firm needs to once again determine where in the U.S. market it’s truly competitive. “What investors want to know is whether Nomura’s business is sustainable.”Nomura has had other setbacks abroad, and has posted pre-tax losses in the Americas for three of the past five years. Once the largest investment bank in the world by market value in the late 1980s, Nomura tried to leverage the expertise of Lehman Brothers by taking over its European and Asian units in 2008, though that contributed to an 81 billion yen ($750 million) writedown two years ago. It suffered one of its biggest trading losses from the collapse of a bond firm in London in 2015, and closed a real estate finance business in San Francisco two decades ago after posting a $700 million loss.Archegos-linked losses at MUFG and Mizuho - estimated at about $270 million and $93 million -- were much smaller but also highlight the risks of stepping out of their comfort zone.MUFG and Mizuho have said they aren’t in the prime broker business. Yet they were exposed to Archegos.MUFG was thwarted from offloading its exposure just as the block-trade frenzy hit the market by their own lawyers, according to a person familiar with the matter. The firm’s legal team concluded that the terms of its contract with Archegos didn’t allow for an immediate unwind and the bank would have to wait a couple of days before they could sell. The firm was stuck with the exposure even as the holdings continued to tank, a situation that ultimately left them tallying outsized losses relative to their total exposure to the family office.The MUFG spokesman declined to comment on the unwinding.Even with the losses, the Japanese firms are unlikely to resist the siren call of Wall Street, home to the biggest pool of bank fees. Risk taking comes with the territory.“You can never become a major international player without doing business in the U.S.,” said Ban.(Updates with share prices)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Company Announcement 23 April 2021 Announcement No. 7 NKT awarded turnkey high-voltage AC order to provide power from shore to Troll West NKT has been awarded a contract for the Troll West electrification project of approx. EUR 95m (approx. DKK 710m) by Equinor Energy AS on behalf of the Troll Unit. Troll West electrification project includes partial electrification of the Troll B platform and full electrification of Troll C in the North Sea. This means that both platforms’ power demand will be met from shore. The project will help cut emissions on the Norwegian continental shelf substantially. The order comprises turnkey supply and installation by NKT Victoria of over 110 kilometres of 145 kV high-voltage AC offshore power cable system with three dynamic sections to electrify the Troll West B and C platforms. NKT President and CEO Alexander Kara says:- The Troll West order is special to us. Not only does it sustain our long-term collaboration with Equinor, it also proves our leading position within dynamic power cables, where we, with this project, increase the voltage level and power transmission compared with previous projects. Furthermore, this power from shore project is another important step in the green transformation of society: Our power cables are produced in a plant running on 100% green electricity and when commissioned the solution will help cut emissions on the Norwegian continental shelf substantially. I am very pleased, that NKT is a key partner in connecting a greener world. Troll West comprises two floating platforms, Troll B and Troll C, and the turnkey power cable solution from NKT includes dynamic cables that connect the two floating platforms with static offshore power cables at the seabed. The power from shore solution will be connected to the national grid at Kollsnes, northwest of Bergen, Norway. Dynamic power cables are an important component when transmitting power to and from floating applications. Here, NKT builds on its vast experience since 2010, where the world’s first high-voltage cables for floating applications were installed. During the past years, NKT has provided power cables solutions to connect several floating platforms with power from shore. These include Gjøa, Goliat and Martin Linge, all of them using dynamic power cables. The power cables will be manufactured in Karlskrona, Sweden, with production start in 2021 and with commissioning in 2023. By sourcing the power cables from the Karlskrona plant, strategically located in close to the North Sea, and installing them with the highly fuel efficient NKT Victoria the carbon footprint of the entire transportation and installation campaign is kept at a minimum. The contract value of approx. EUR 95m in market prices corresponds to approx. EUR 85m (approx. DKK 630m) in standard metal prices. The award of the Troll West project does not change the 2021 financial outlook for NKT. The contract is subject to the government approval of the plan for development and operation for the Troll West electrification project. ContactInvestor Relations: Michael Nass Nielsen, Head of Investor Relations, Tel.: +45 2494 1654Press: Pelle Fischer, External Communications Lead, Tel.: +45 2223 5870 Attachment NKT_awarded_turnkey_high-voltage_AC_order_to_Troll_West
Major players in the nebulizer devices market are Agilent Technologies, Becton Dickinson and Company, Koninklijke Philips N. V. , Omron Corporation, Covidien plc, GE Healthcare Ltd. , Allied Healthcare Products, Inc, Briggs Healthcare, PARI Pharma, and GF Health Products, Inc.New York, April 23, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Nebulizers Global Market Report 2021: COVID 19 Implications And Growth to 2030" - https://www.reportlinker.com/p06065178/?utm_source=GNW The global nebulizers market is expected to decline from $1.67 billion in 2020 to $1.04 billion in 2021 at a compound annual growth rate (CAGR) of -37.7%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $1.55 billion in 2025 at a CAGR of 10.5%.The nebulizer devices market consists of sales of nebulizers used in respiratory care for patients with respiratory diseases including asthma, cystic fibrosis and COPD. The sales consist of revenues generated by establishments that are primarily engaged in the manufacturing of breath actuated and vented pneumatic nebulizers, portable and standalone ultrasonic nebulizers, and static and vibrating type mesh nebulizers.The current Covid-19 pandemic has resulted in a surge in demand for nebulizers.There has been an increased use of albuterol inhalers in hospitals for Covid-19 and suspected Covid-19 patients to help with respiratory issues.This is mainly because respiratory viruses are the most common trigger for asthma exacerbations.Nebulizer therapy requires a device that repeatedly and quickly delivers sufficient drug with minimal wastage, to the site of action.However, during nebulization aerosol with a smaller particle size are inhaled or delivered to the site of action while large particles return to reservoir feeding tube.Also, some of the drug aerosols settle on the walls of the baffle.This drug is retained within the nebulizer, (also called as residual drug or dead volume) or released into environment during expiration.This results in drug wastage.Drug wastage during exhalation is therefore challenging the growth of nebulizer market.The development of technically advanced novel nebulizers is however expected to reduce drug wastage and improve delivery efficacy.The technologically advanced nebulizers including breath-enhanced, breath-actuated, and vibrating mesh nebulizers decrease the amount of drug lost during exhalation while increasing the efficiency of drug delivery and shaping the nebulizer devices market.For example, in June 2020, Respira Technologies, a health technology platform development company, revealed the introduction of a pharmaceutical-focused commercial development programme for its RespiRx drug delivery system.Respirx is a compact, hand-holding vibrating mesh nebulizer built for local and systemic treatment and can work in any position placed by the patient. The latest and advanced nebulizers increase the output rate which in turn will decrease the administration time.Rising geriatric population across the globe is expected to increase the usage of respiratory care devices including nebulizers over the forecast period.For instance, according to the World Health Organization (WHO), by 2050, the world’s population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015.As of 2019, 143 million people are aged 80 years or older. According to the United Nations, in 2020, the global population of person aged 65 years and older was estimated to be 727 million and this number is projected to nearly double to over 1.5 billion in 2050. Elderly people are more susceptible to respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), sleep apnea, and the recent pandemic COVID-19 for many factors including gradual decline of immune function. Therefore, rise in geriatric population is anticipated to propel the nebulizer market growth.Read the full report: https://www.reportlinker.com/p06065178/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
It's reasonable to assume that the federal prohibition of marijuana is deterring many companies from getting involved with the cannabis industry. While there have been marijuana-related transactions, investors know that many pharmaceutical and even tech companies could be chomping at the bit to get involved -- once the path is clear. In an interview earlier this month with CNBC, Uber (NYSE: UBER) CEO Dara Khosrowshahi said, "When the road is clear for cannabis, when federal laws come into play, we're absolutely going to take a look at it."
(Bloomberg) -- Futures rose Friday as investors digested a proposal for higher taxes to pay for President Joe Biden’s fiscal stimulus.Contracts on both the S&P 500 Index and Nasdaq 100 posted modest gains, signalling the U.S. gauges may be poised to rebound from sharp declines on a Bloomberg News report Biden plans to nearly double the capital gains rate on the wealthy. Intel Corp., the biggest chipmaker, fell 2.7% in premarket trading following a slump in gross profit margin. Treasuries and the dollar dipped.Investors are weighing the implications of higher taxes against the potential spillover benefits of spending on infrastructure. While loose central bank policy is helping support stocks near record highs, these levels look precarious given worsening news about the spread of Covid-19 in parts of the world.Read: Fat Valuations and Tech Stocks Seen as at Risk in Biden Tax Plan“We don’t think it derails the equity market recovery,” said Nupur Gupta, portfolio manager at Eastspring Investments, said of the tax proposal on Bloomberg TV. “Equity sentiment does appear to be stretched, which is why any negative news that you get can lead to a consolidation in markets in the short term.”European stocks fell amid a mixed batch of earnings. Carnival Plc shares dropped as much as 4.4% in London after Morgan Stanley flagged caution on cruise lines. Swedish telecom Telia Co. also declined despite first-quarter results in line with forecasts.Meanwhile, oil edged higher, still on course for a weekly drop of about 2.5% as energy demand wavers with the virus rampant in key markets outside the U.S.Elsewhere, Bitcoin slid below $50,000, headed for its seventh loss in eight days. Investors already face a capital-gains tax if they hold the cryptocurrency for more than a year.The U.S. releases new home sales data later on Friday.These are some of the main moves in markets:StocksFutures on the S&P 500 Index climbed 0.2% as of 6:16 a.m. New York time.The Stoxx Europe 600 Index declined 0.4%.The MSCI Asia Pacific Index increased 0.3%.The MSCI Emerging Market Index gained 0.6%.CurrenciesThe Bloomberg Dollar Spot Index declined 0.3%.The euro jumped 0.3% to $1.2055.The British pound rose 0.3% to $1.3884.The onshore yuan weakened 0.1% to 6.494 per dollar.The Japanese yen strengthened 0.1% to 107.90 per dollar.BondsThe yield on 10-year Treasuries rose one basis point to 1.55%.The yield on two-year Treasuries gained less than one basis point to 0.15%.Germany’s 10-year yield sank one basis point to -0.27%.Japan’s 10-year yield decreased less than one basis point to 0.071%.Britain’s 10-year yield declined one basis point to 0.73%.CommoditiesWest Texas Intermediate crude rose 0.1% to $61.51 a barrel.Brent crude decreased 0.1% to $65.36 a barrel.Gold strengthened 0.1% to $1,785.63 an ounce.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Protesters marched through downtown Yangon Friday to demand that regional leaders "stand with Myanmar people", ahead of a weekend ASEAN summit attended by junta leader Min Aung Hlaing.
Dublin, April 23, 2021 (GLOBE NEWSWIRE) -- The "Digital Signage Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global digital signage market reached a value of US$ 21.1 Billion in 2020. Digital signage refers to a centralized content distribution platform used to playback information on multiple display screens. It shows advertisements or messages to the targeted audience through content management software (CMS) and a back-end operating computer connected to a media player. It utilizes devices, such as projectors, LCD, LED and plasma displays, to project or show the information, including live weather forecasts, news, television programs, menus, flight schedules, calendars and advertisements. Digital signages are commonly used in various sectors such as retail, entertainment, hospitality, education, corporate, healthcare, transport, etc. They enable the organizations to engage with a broader audience and create a centralized network for digital communications to enhance the uniformity and effectiveness of the marketing activities.Rapid digitalization, along with the increasing demand for effective advertisement tools, is one of the key factors driving the growth of the market. Furthermore, widespread utilization of electronic large-screen displays in various industrial sectors, such as retail, hospitality, entertainment, banking, healthcare, education and transport, is stimulating the market growth. For instance, in the banking sector, digital signages are used in automated teller machines (ATMs) and e-banking centers to display motion messages, digitalized promotion of products and remote content updating and management. Additionally, various technological advancements, such as the integration of biometric technology with digital signage products, are acting as other growth-inducing factors. In line with this, modern product variants are equipped with gaze trackers and heat path trackers that locate the area that is attracting the most consumers, thereby enabling organizations to monitor consumer behavior and gaining meaningful insights. Other factors, including improvements in the LCD/LED technologies, along with increasing expenditures on brand promotions and advertisements, are anticipated to drive the market further. Looking forward, the publisher expects the global digital signage market to exhibit moderate growth during the next five years. Competitive Landscape: BARCOLeyard Optoelectronic (Planar)LG ElectronicsPanasonicSamsung ElectronicsShanghai Goodview ElectronicsSharp (Foxconn Group)Sony Key Market Segmentation:Breakup by Type: Video WallsVideo ScreenTransparent LED ScreenDigital PosterKiosksOthers Breakup by Component: HardwareSoftwareService Breakup by Technology: LCD/LEDProjectionOthers Breakup by Application: RetailHospitalityEntertainmentStadiums and PlaygroundsCorporateBankingHealthcareEducationTransportOthers Breakup by Location: IndoorOutdoor Breakup by Size: Below 32 Inches32 to 52 InchesMore than 52 Inches Breakup by Region: North AmericaUnited StatesCanadaAsia PacificChinaJapanIndiaSouth KoreaAustraliaIndonesiaOthersEuropeGermanyFranceUnited KingdomItalySpainRussiaOthersLatin AmericaBrazilMexicoOthersMiddle East and Africa Key Questions Answered in This Report: How has the global digital signage market performed so far and how will it perform in the coming years?What has been the impact of COVID-19 on the global digital signage market?What are the key regional markets?What is the breakup of the market based on the type?What is the breakup of the market based on the component?What is the breakup of the market based on the technology?What is the breakup of the market based on the application?What is the breakup of the market based on the location?What is the breakup of the market based on the size?What are the various stages in the value chain of the industry?What are the key driving factors and challenges in the industry?What is the structure of the global digital signage market and who are the key players?What is the degree of competition in the industry? For more information about this report visit https://www.researchandmarkets.com/r/k6oal4 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Find the best probiotic supplements in 2021 and review top natural gut healing health formulas with potent beneficial probiotics and no negative side effects.Chicago, IL, April 23, 2021 (GLOBE NEWSWIRE) -- Probiotic supplements are one of the hottest new trends in the supplement industry. New research has found that the gut flora, or the bacteria in our digestive tract, plays a more important role in our health than we previously thought. Probiotics are an easy way to improve the health of your gut flora to ensure you have plenty of good bacteria in your digestive tract. Hundreds of companies are joining the probiotic train and taking advantage of the new interest in probiotics. This can make finding the best probiotics very difficult. After extensive research, our dedicated team has thoroughly evaluated dozens of probiotics and found the very best probiotics that maximize effectiveness without sacrificing safety. Here are the best probiotics for 2021 and beyond: Ranking the Best Probiotics in 2021 There’s a reason why some supplement websites have created entire guides about the ins and outs of probiotic dietary supplements. The probiotic and prebiotic industry has always been filled with misinformation, and the terms and phrases used within the supplement have long been a source of confusion for consumers trying to start on the ground floor. One guide we read promised to “strip away some of the difficult language” of the industry and put it into words that the average reader would understand. We considered this advice carefully when crafting today’s comprehensive guide. We plan to run users through lists of the top probiotic dietary supplements available in 2021. Throughout the guide, you may see us use terms like microbes, good bacteria, and more. This kind of specific language can be difficult for new supplement users to understand, so we plan to start with a brief introduction into the nature of the probiotic supplement industry. It might be helpful to trace the word “probiotic” back to its roots. Probiotic means “pro-life,” and the research currently associated with the growing probiotic supplement industry makes this name extremely fitting. Probiotic supplements work by introducing “good bacteria” into the body. Some people operate under the assumption that all bacteria is bad and causes disease and infection. In truth, some bacteria are natural and very good for the health of the body. There are actually four unique strains of bacteria native to the human gut. Having too much bad bacteria can create infection and illness. But an equally significant problem experienced by some people is the opposite; they have too few good bacterial strains in their body. Around 500 or more unique species of bacteria naturally live in the human body, meaning that true health and wellness has a lot to do with balancing good bacteria with bad. Probiotics help to create more good bacteria in the body. While the body naturally facilitates the growth of some bacterial strains in the gut and the rest of the body’s organs, probiotic supplements provide a bit of extra help to people who need it. The growth of new bacterial colonies in the gut and other parts of the body can be an important step in the healing process for people who have experienced deteriorating colon and gut health. Doctors will prescribe medications to help with the growth of certain bacterial strains, and eating foods like yogurt is a good way to ensure that your body gets all the bacteria it needs to function. Are you looking to improve your health and wellness by using probiotic supplements? Scams are certainly common within this industry, which continues to grow in popularity every year. We do not want users who are already suffering with gut and colon issues to fall victim to scam formulas. Supplements in this guide have been carefully vetted so that we can bring you only the highest quality ingredients, the most reputable manufacturers, and the most scientifically supported formulas available. Navigating the world of gut health is exceedingly difficult. Although gut and colon health has been a concept in the medical world for hundreds of years, doctors still don’t know everything there is to know about this complicated part of the body. Imbalance in the gut can be easy to detect, but almost impossible to genuinely treat. The best way to improve gut health involves a combination of medication and lifestyle change. Regardless of which top probiotic supplement formula you choose to use, combining the formula with a solid diet and regular exercise is essential to long-term treatment success. But you’re not here for a lesson eating right and following the doctor’s orders. The question on most consumers’ minds is the same: are probiotic supplements really helpful? Top Rated – 1MD Complete Probiotics In the world of probiotics, 1MD Complete Probiotics is in a class of its’ own. Each capsule of Complete Probiotics has an astounding 51 billion live CFUs and 11 different strains of bacteria for maximum biodiversity. This increases the chance for a healthier, balanced gut biome. To prevent the destruction of CFUs in the stomach, Complete Probiotics uses delayed release capsules to ensure probiotics safely reach the intestines. Once they are there, the patented Nutraflora® prebiotic fiber nourishes the probiotics to optimize effectiveness and deliver results unlike any other probiotic supplement we researched. 1MD Complete Probiotics is manufactured in an FDA-registered lab using GMP practices. Their capsules are vegan, non-GMO, gluten-free, soy free and preservative free. Simply put, there is no better probiotic supplement out there than 1MD Complete Probiotics. If you’re a beginner you may want to try a lower dosed product to get used to probiotics but you’ll likely end up with Complete Products. Runner Up Probiotic – BioTrust Pro-X10™ We’ve reviewed hundreds of different supplements and compiled dozens of lists of the best supplements in various individual categories. Time and time again BioTrust products rank amongst the best, if not the best. Their probiotic supplement BioTrust Pro-X10™ is no different. Pro X-10 combines 5 billion CFUs with 7.5 grams of patented prebiotic to support a healthy balance of gut bacteria, improve digestion, and enhance immune function. Pro-X10 contains six different strains of bacteria including three strains of lactobacillus, which are among the most well researched probiotic bacteria known to man. Additionally, Pro-X10 contains a patented microencapsulation technology to prevent the breakdown and destruction of the probiotic ingredients before they enter the gut. Overall, there is not a negative thing to say about Pro-X10. It has well researched strains of bacteria, prebiotics to help feed probiotic bacteria, and its’ manufactured by one of the most well-respected supplement companies in the world. You simply cannot go wrong with BioTrust X-10. #3 – Garden of Life RAW Probiotics Garden of Life RAW Probiotics is one of the top selling probiotic supplements on Amazon with an astounding 2,753 customer reviews and an average rating of 4.6. Each capsule of RAW Probiotics contains an incredible 100 billion CFU, which is one of the highest amounts of CFUs we could find. Likewise, RAW Probiotics uses 34 different strains of bacteria to improve gut bacteria. Several of these strains are specifically designed to enhance immunity as well. If you’re looking for a high-dose, biodiverse probiotic product, then you won’t find a product that suits your needs more than Garden of Life Raw Probiotics. #4 – Organifi Balance Balance is a fairly new product from the well-respected supplement company Organifi. Each portable stick contains 20 billion CFUs and 3mg of VitaFiber®, a patented form of fiber that acts as a prebiotic to nourish bacteria in the gut. In total, there are 5 different strains of bacteria in Organifi Balance so it’s not necessarily the most biodiverse probiotic on the market. However, Balance does contain three of the most thoroughly researched probiotic strains so when you combine it with a solid dosage of 20 billion CFUs, you can feel safe knowing you’ve got a solid probiotic on your hands. #5 – BioFit Probiotic BioFit Probiotic claim to fame is that it has the most live CFUs that target weight loss specifically we could find in any of the products we reviewed. In one just capsule there are an unbelievable 5.75 billion CFUs bacteria per pill. This is 4 to 5 times the normal number of bacteria found in most probiotics that cater towards weight loss in our research. There are also seven different strains of bacteria in BioFit so it is fairly biodiverse led by the patent pending DE111 ingredient. All seven of the strains are popular strains and thoroughly researched so you can rest easy knowing they are effective as these are hailed as miracle microbes by Nature's Formulas. Our favorite thing about BioFit probiotic is the diverse number of strains though. BioFit has their potent strength 5.75 CFUs probiotics as their flagship product. However, they also have an incredible 180-day money back guarantee (with no prescription needed) that specifically target fat burning and optimal digestion. They all have the special spore delivery system to ensure the probiotics do not get destroyed by stomach acids too If you’re looking for the highest dose weight loss probiotic you can find, then BioFit Probiotic by Nature's Formula is a fantastic solution. #6 – LiveWell Pro-45 Pro-45 is another top-quality product from the popular LiveWell line of supplements. LiveWell Pro-45 is made with 45 billion live cultures and 11 different clinically studied strains - all of which are proven to assist with acid and bile resistance. LiveWell also adds NutraFlora® prebiotic to help further boost the vitality and growth of gut flora to maintain a healthy balance in your gut. There’s nothing fancy about Pro-45. It doesn’t contain the most CFUs per dose and it doesn’t have the most strains of bacteria. However, it does come with a the combine the best of both worlds with clinically studied probiotics and prebiotics and therefore it’s an excellent choice, especially if you already are a LiveWell customer. For an added bonus, it won’t break the bank like many of other popular probiotics either. Our Ranking Factors The two most important factors in any probiotic supplement are the specific strains of bacteria used as well as the dosage of each strain within the product. Both of these factors were the two most important factors we considered. Specific bacteria strains: Most clinical studies have researched a specific bacteria strain, not several strains the way most probiotics are formulated. We compiled a list of individual bacteria strains involved in clinical studies and gave preference to those that were attributed to specific health benefits. We then looked for probiotics that contained several of these bacteria strains because we felt they were more likely to amplify the potential benefits. Five or more individual strains of bacteria was our preference and we had a “the more, the better” mentality when researching products. Dosage: Probiotic dosage comes in the form of CFUs, or colony forming units. CFUs are the number of live bacteria within a probiotic supplement. Since bacteria are microscopic, the dosage of CFUs will often number in the several billions. Dosage is important because a large percentage of bacteria in probiotics won’t actually make it to your gut. This is because most of the CFUs are destroyed in your stomach before they can get digested and work their way to your gut. This is why it is best to have a probiotic with at least 10 billion CFUs per serving. Clinical studies have used higher doses of upwards of 50 billion CFUs, so higher doses are even better and are still considered safe. Delivery systems: Since most of the CFUs in probiotics will never make it to your gut, specialized delivery systems are becoming more popular to protect more of the CFUs. Things like microencapsulation, adding fat molecules, or using an extended release formula are all examples of specialized delivery systems meant to improve the effectiveness of probiotics. These mechanisms prevent the stomach from breaking down and killing the majority of the CFUs so more bacteria can reach your gut and potentially improve your health. We can some extra consideration to probiotic products that contained one of these specialized delivery mechanisms. It was not a requirement since a probiotic of 100 billion CFUs can still be just as effective as a probiotic with 10 billion and a specialized delivery system. However, we still felt there was likely a better chance to feel real results in products that protected the bacteria. Product purity and design: Finally, we applied our standard for product purity and good manufacturing practices. We wanted products manufactured in an FDA-registered facility that maintained strict good manufacturing practices. We also considered products that clearly labeled what strains of bacteria were in their product and the dosage. Additionally, we looked for products that also contained prebiotic ingredients since they help feed gut flora to keep the good bacteria in your gut healthy. Get the #1 Best Ranked Probiotic Supplement for Natural Gut Healing and Digestion Optimization in 2021 Today Benefits of Probiotics Clinical research has demonstrated clear health benefits to taking probiotics. A healthy gut flora is beneficial to your immune system function, digestion, weight management, and hormone production. In addition, women tend to benefit more from probiotics than me because probiotics have demonstrated the ability to improve vaginal health and to reduce the risk of yeast infections. Probiotics can improve digestion and eliminate digestion problems: The primary focus of clinical research involving probiotics has been its’ relationship with digestion and digestive disorders. Research has shown a clear connection with probiotics and improved digestive function. One study conducted in France found that probiotic supplements improved digestive health and eliminating common digestive issues like diarrhea and constipation. They concluded that probiotics increase resilience of the intestinal wall to destructive agents. Probiotics can also reduce disease related changes to intestinal structure, which can cause stomach pain, diarrhea, and bloating. Their research suggests probiotics can be beneficial for virtually any digestive problem ranging from simple digestive problems like diarrhea all the way to irritable bowel disease and ulcerative colitis. In fact, a follow up study in 2009 confirmed this when adults with ulcerative colitis saw remission after taking probiotics. Probiotics can help treat and prevent yeast infections and urinary tract infections: Urinary tract infections and yeast infections are the result of fungi or harmful bacteria colonizing in the urinary or genital tract. Healthy bacteria would normally be able to remove these harmful pathogens and prevent their reproduction and colonization. Probiotics are quickly becoming a popular treatment and prevention method for yeast and urinary tract infections. Studies have shown that the lactobacillus strain of bacteria is particularly effective and most probiotics targeted towards women will contain a large dose of lactobacillus. Probiotics may help stop weight gain and even cause weight loss: The exact link isn’t quite known but researchers believe that bad bacteria can slow down the body’s ability to burn off energy by inhibiting the production of certain hormones that control your metabolism. Bad bacteria can also slow down the body’s ability to digest food which may cause weight gain due to severe constipation. More research is still needed in this area but there is an overwhelming amount of anecdotal evidence available. A significant portion of individuals that take probiotics have reported losing weight - especially during the first few weeks of use. Therefore, it appears that there is a real link between probiotics and healthy weight management. Probiotics support healthy immune system function: Your immune system is a large and complicated system spread throughout your entire body – but it starts in the digestive tract. Researchers believe that probiotics can help support the immune system by introducing good bacteria into your gut that kill off the bad bacteria and other pathogens that otherwise will harm your body. One study even found that probiotics may reduce or alleviate allergies all together by helping your immune system focus on bad pathogens and not on allergens. Probiotics may help balance hormones: Believe it or not but the bacteria in your gut play a huge role in the production of important hormones in your body. The estrobolome is a collection of bacteria in the gut that influence the circulation of estrogen. This can affect libido, weight gain, and mood - especially in women. In addition, gut bacteria influence the body’s rate of digestion and the production of metabolic hormones that control weight. In a study conducted by the Imperial College London, researchers found probiotics could change how much fat the body absorbed by changing the way bile acids are metabolized. Researchers believe that probiotics can regulate how much fat the body can absorb, potentially blocking the storage of new fat. (HUGE SAVINGS TODAY) Save Big on the #1 Top Ranked Probiotics Pill for Digestive Support and Weight Loss Management Safety and Side Effects of Probiotics In general, probiotic supplements are generally recognized as safe and tolerated well by most individuals. However, there are a few potential side effects, especially during the first few days of use. Digestive issues are the most common side effect associated with probiotics. Gas, bloating, and constipation can occur, although these side effects typically disappear after a few days of use. There is some evidence that certain strains of probiotics may cause histamine in the digestive tract. Those with a sensitivity or allergy to histamine may experience an allergic reaction and experience watery eyes, runny nose, itching, or trouble breathing. Although potentially serious, the chance for this reaction to occur is very minimal at best. Recommended Dosage Probiotic supplements are fairly new and have only been really studied for about a decade. As you can expect, the dosage used in clinical trials is all over the place. Another issue is that most clinical trials focus on a specific strain of bacteria whereas most supplements contain several strains of probiotics. Still we can still figure out a rough idea of what to look for as far as dosage is concerned. In a dozen+ studies, the minimum dosage we found was ten billion CFUs (colony forming units). Most studies used an even greater dosage between fifty and one hundred billion CFUs All of the clinical studies evaluated participants over multiple months. This indicates that even at high doses, probiotics might take a while for you to see the full effects. In general, take a higher dose of probiotics since a significant portion of the bacteria are destroyed by your digestive system during digestion. (LOWEST PRICE ONLINE) Get the Best Probiotic Weight Loss Supplement Directly from the Official Website for the Biggest Discount FAQQ. What exactly are probiotics? Probiotics are living organisms found in your digestive tract that are responsible for supporting healthy gut flora. Having a healthy gut flora has been linked to another of health benefits like weight loss, better digestion, healthier skin, and enhanced immune function. It is possible to take probiotics through your diet in foods like yogurt, pickles, and sauerkraut. Unfortunately, most people cannot consume these foods on a regular basis, which is why probiotic supplements are common. Q. Do I really need a probiotic? Experts disagree on whether or not you actually need a probiotic. Evidence suggests probiotics can be very beneficial to your health, but may not be necessary. However, if you’ve been taking an antibiotic, then a probiotic is an especially good idea. That’s because probiotics kill the bacteria in your gut, including the good bacteria. This can throw off your gut flora, which need replacing. In this case, taking a probiotic can quickly replace the good bacteria lost while taking antibiotics. For most people, taking a probiotic isn’t a necessity, but it certainly can help improve digestion and immune system. Q. What are some of the benefits associated with probiotics? Taking probiotic supplements have proven health benefits. Studies have shown that probiotic supplements can help improve digestion & immune system function. Other studies found that bad gut flora can slow the body’s metabolism and diminish the body’s production of essential hormones. This can cause bloating and weight gain. Taking probiotics may reverse this effect and aid in weight loss in some individuals. Q. What’s the difference between probiotics and prebiotics? Both probiotics and prebiotics are vital to your health. However, they have two very different functions and it’s important to know the difference. Prebiotics are substances that come from carbs (mostly fiber) that humans cannot digest. When consumed, prebiotics past through the digestive tract and are then eaten by healthy bacteria in the gut. This helps the bacteria flourish and maintains a healthy gut flora. Probiotics are live bacteria that live in foods or supplements. Probiotics help support a healthy gut flora, which has been linked to almost a dozen benefits. Eating both prebiotic and probiotic foods are very important for various bodily functions and maintaining the right balance will keep your gut microbiota healthy. Q. Are there any side effects of probiotics? While probiotics are considered generally recognized as safe and tolerated by most people, there can be side effects. Most people will not experience side effects, but for those that do, the most common side effects are gas and bloating. These side effects typically subside after a few days or a few weeks. Certain strains of probiotics may produce histamine in the digestive tract. This can trigger an allergic reaction and cause symptoms like itching, watery eyes, runny nose, or trouble breathing. To mitigate the risk of side effects, it is recommended you start with a lower strain of probiotics and work your way up to a higher dose. Q. Can probiotics help with weight loss? It is possible for probiotics to aid in weight loss, although not directly. There is some evidence that a bad gut flora can interfere with the production of certain hormones that regulate the body’s metabolism. Studies have shown that improving gut flora can help manage the body’s production of hormones – including those that control the body’s metabolism. Therefore, it’s very possible to see some minor weight loss when taking a probiotic. Q. How many CFUs are good for a probiotic? Most probiotics contain anywhere from 1 billion to 100 billion colony forming units, or CFUs. However, the # of CFUs is not nearly as important as other factors. The delivery system and quality of strains is far more important and effective than the # of CFUs. A high quality probiotic will contain several essential individual strains of bacteria and a delivery system that protects the probiotics as they enter your digestive tract. (SPECIAL SAVINGS) Find the Most Popular Probiotic Health Supplement for Losing Weight Right Now Recap The common saying now is that your gut flora is the key to your overall health. Research is quickly finding that this is very true. In fact, a healthy gut flora is essential to your digestion system function, immune system function, your hormone production, and your metabolism. With the right strains of bacteria and a proper delivery system, probiotics can be an effective way to keep your gut flora healthy and make sure your body is operating smoothly. The answer is an unmitigated “yes.” Probiotic supplements are relatively new in their latest forms, and most of the formulas on our list were first created in the past few years. But the concept behind these interesting supplements has been around for many decades. Scientists have known for over a century that the body is filled with both good and bad bacteria. Only recently have some probiotic supplement companies figured out how to spur bacterial colony growth within the body. A few common bacterial strains are featured in most probiotic formulas. Lactobacillus, Bifidobacterium, and a few other strains are extremely popular. Most supplements on our list include a combination of these strains for maximum effectiveness. The best probiotic supplements are frequently composed exclusively of these strains; it isn’t necessary to combine a long list of additional ingredients to make this supplementation concept work. Probiotic formulas also help people to fight pathogens, build immunity, metabolize hormones, and even synthesize key vitamins and minerals. Probiotics are also frequently combined with probiotics to help provide a more comprehensive treatment plan for people who want to improve overall digestive health. Probiotic bacterial strains are actually fed by prebiotics. Probiotics, when used properly, can help both men and women in a long list of different ways. Who should use the probiotics on the list above? Our general answer: anyone. Anybody can use probiotics to help boost immunity, maximize gut health, and improve the digestive process. The main target audience for most of these supplements is aging people, but this is only because elderly men and women are most likely to suffer from some sort of problem involving the gut. The reality is that nearly anyone can develop these issues, and a great way to avoid long-term issues in the gut as we age is to turn toward probiotic supplementation. It’s not easy to navigate the world of probiotic supplementation. The confusing terms surrounding the industry can make it difficult for new consumers to find the formulas that are right for them. We hope that the guide above provides you with enough background information to make a more informed decision about the top probiotic supplements of 2021. If you are interested in using a formula like the ones above, we encourage you to conduct your own research and consider trying probiotics today! Buy the Best Rated, Top Ranked, Most Popular Probiotic Supplement for Weight Loss Today Official Website: https://nucific.com/ Contact Details: Nucific Email: email@example.com Phone: 1-888-679-5520 About MarketingByKevin.com This product review is published by Marketing By Kevin. Marketing By Kevin reviews are researched and formulated by a group of experienced natural health advocates with years of dedication and determination to finding the highest quality health products and wellness programs available. It should be noted that any purchase derived from this resource is done at your own peril. It is recommended to consult with a qualified professional healthcare practitioner before making an order today if there are any additional questions or concerns. Any order finalized from this release’s links are subject to the entire terms and conditions of the official website’s offer. The researched information above does not take any direct or indirect responsibility for its accuracy. Affiliate Disclosure: The links contained in this product review may result in a small commission to Marketing By Kevin if you opt to purchase the product recommended at no additional cost to you. This goes towards supporting our research and editorial team and please know we only recommend high quality products. Disclaimer: Please understand that any advice or guidelines revealed here are not even remotely a substitute for sound medical advice from a licensed healthcare provider. Make sure to consult with a professional physician before making any purchasing decision if you use medications or have concerns following the review details shared above. Individual results may vary as the statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. Product support: firstname.lastname@example.org Media Contact: email@example.com CONTACT: Kevin Mahoney 708-247-1324 firstname.lastname@example.org
Residents in Elmbridge have described the tree-felling as ‘mindless vandalism’
Pakistan's parliament on Friday again deferred debating the fate of the French ambassador, with the government seemingly putting a lid on bloody anti-France protests that rocked the country for a week.
Seven puppies, just three days old, were found dumped on a Queensland beach.
Investors in Ocugen (NASDAQ: OCGN) at the start of the year have reason to cheer. The stock has been flying high amid optimism about a deal to co-commercialize a potential coronavirus vaccine in the U.S. Now, the question is whether it's too late to get in on this story -- or if Ocugen's share gains are only just beginning.
The "World - Plastic Parts For Lamps and Lighting Fittings - Market Analysis, Forecast, Size, Trends and Insights" report has been added to ResearchAndMarkets.com's offering.
The Board of Directors of The Gorman-Rupp Company (NYSE: GRC) has declared a quarterly cash dividend of $0.155 per share on the common stock of the Company, payable June 10, 2021, to shareholders of record May 14, 2021. This will mark the 285th consecutive quarterly dividend paid by The Gorman-Rupp Company.
Major players in the ventilator devices market are Philips Healthcare, ResMed, Medtronic, Becton, Dickinson and Company, GE Healthcare, Hamilton Medical, Dräger, Getinge, Smiths Group, and Fisher & Paykel.New York, April 23, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Ventilators Global Market Report 2021: COVID 19 Implications And Growth to 2030" - https://www.reportlinker.com/p06065179/?utm_source=GNW The global ventilators market is expected to decline from $12.11 billion in 2020 to $3.46 billion in 2021 at a compound annual growth rate (CAGR) of -71.4%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $4.67 billion in 2025 at a CAGR of 7.8%.The ventilator devices market consists of sales of ventilators used in respiratory care for patients with acute or chronic respiratory disorders. The sales consist of revenues generated by establishments that are primarily engaged in the manufacturing of intensive care ventilators (critical care ventilators), neonatal care ventilators, and portable & transportable ventilators.There is an urgent and increased need of ventilators globally.This is because Covid-19 primarily manifests as an acute respiratory illness with pneumonia, and ventilators are the main supportive treatment for critically-ill patients.They assist or replace respiratory functions, pumping oxygen into the blood for vital organs. Therefore, the ventilators market is expected to grow significantly with the rapidly increasing cases of Covid-19 disease worldwide.The number of complications associated with the use of ventilators is expected to negatively affect the ventilators market.The ventilators cause complications including bronchopleural fistula, pneumothorax and nosocomial pneumonia and similar complications that result in decrease in cardiac output, gastric problems and renal impairment, alkalosis.According to a report by Northwell Health COVID-19 Research Consortium in 2020, the death rate rose to 88% for those who received mechanical ventilation. The analysis of the report states that most of the patients could not survive after being placed on mechanical ventilator.The companies in the ventilator market are increasingly expanding their ventilator production capabilities realizing the current demand due to the outbreak of the COVID-19 pandemic.COVID-19 is a respiratory disease caused by corona virus that infects lungs causing pneumonia and other respiratory conditions.The patients affected with the virus suffer with severe pneumonia and lung dysfunction resulting in need for the ventilator support for respiration.For instance, in March 2020, Medtronic, a leading medical device manufacturer increased its ventilator production by 40%.Also, in March 2020, Philips targeted to increase its ventilator production capacity by 4-fold, to meet the rising demand.In April 2018, Vyaire Medical, a USA based respiratory device manufacturer acquired Acutronic for an undisclosed amount.Through this acquisition, Vyaire will strengthen its position in the ventilator market by entering into neonatal ventilator segment.Acutronic is a leading manufacturer of neonatal ventilator equipment.Rising prevalence of respiratory diseases is driving the ventilators market.The chronic respiratory diseases such as asthma, bronchitis, pneumonia, and others resulting from different bacterial and viral infections and other causes will boost the demand of ventilators.The ventilators are respiratory devices that are used to support respiration in patients with chronic respiratory diseases. For instance, as of December 2020, 67.9 million COVID-19 cases were reported. Corona virus infects lungs causing pneumonia and other respiratory disorders affecting patient’s respiration. The emergence of such infectious diseases resulting in pandemic is driving the ventilators market.Read the full report: https://www.reportlinker.com/p06065179/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
A major PR agency chief said: “It’s booming right now. Staff know they have options and it’s a job to try and keep them”
Some of Wall Street's biggest names are predicting a pause in a rally that has taken the S&P 500 to fresh records this year, leaving investors trying to determine whether to lock in some of the breathtaking gains or stay the course. Among the most recent has been Goldman Sachs, whose analysts on Wednesday said an expected second-quarter peak in U.S. growth could be tied to weaker stock returns. Morgan Stanley earlier this week warned stocks would soon face headwinds.
Up your luggage game – or finally organise that bathroom cabinet – with these oh-so-trendy toiletry bags